Does pregabalin (lyrica) affect the menstrual cycle?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pregabalin's Effects on the Menstrual Cycle

Pregabalin (Lyrica) does not have direct documented effects on the menstrual cycle in humans, but it may indirectly affect reproductive hormones in some patients through its actions on the endocrine system.

Mechanism and Potential Effects

Pregabalin works by binding to voltage-gated calcium channels, which can have widespread effects throughout the body beyond its primary therapeutic actions. While there is no direct clinical evidence showing that pregabalin specifically disrupts menstrual cycling in women, several mechanisms may explain potential indirect effects:

  • Pregabalin may influence hormone levels through central nervous system pathways that regulate the hypothalamic-pituitary axis 1
  • Animal studies have shown that high-dose or long-term pregabalin use can affect reproductive hormones, though these findings cannot be directly extrapolated to humans 2, 3
  • In animal models, pregabalin has been shown to decrease testosterone levels while increasing FSH, LH, and prolactin 2

Clinical Evidence and Considerations

The FDA-approved drug label for pregabalin does not list menstrual irregularities as a common adverse effect 4. This suggests that if such effects occur, they are likely uncommon or not well-documented in clinical trials.

When considering medications that might affect menstrual cycles:

  • Medications that affect the central nervous system, including some antiepileptic drugs, can potentially influence the hypothalamic-pituitary-gonadal axis 5
  • Hormonal fluctuations within the menstrual cycle may theoretically influence drug pharmacokinetics, though systematic investigations are limited 6
  • Weight changes associated with pregabalin use could indirectly affect menstrual cycles, as pregabalin has been associated with both weight gain and, in some cases of high-dose use, weight loss 1, 3

Risk Factors for Potential Effects

Certain patients may be at higher risk for experiencing reproductive or hormonal effects from pregabalin:

  • Patients taking high doses (≥600 mg/day) for extended periods 7
  • Patients with pre-existing hormonal imbalances or menstrual irregularities
  • Patients taking multiple medications that affect the central nervous system
  • Patients with epilepsy, who may already have a higher baseline risk of reproductive endocrine disorders 5

Monitoring Recommendations

For women taking pregabalin who are concerned about menstrual effects:

  • Monitor for changes in menstrual cycle regularity, duration, or flow
  • Be aware that weight changes from pregabalin might indirectly affect menstrual cycles
  • Consider tracking menstrual cycles before and during pregabalin therapy to identify any changes

Alternative Considerations

If menstrual irregularities develop while on pregabalin and are concerning:

  • Consider alternative medications for neuropathic pain such as duloxetine, which may have different side effect profiles 1
  • For localized neuropathic pain, topical treatments like capsaicin may be considered as alternatives with fewer systemic effects 1

While direct evidence linking pregabalin to menstrual cycle disturbances is limited, patients should report any new or worsening menstrual irregularities to their healthcare provider for appropriate evaluation and management.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.